Anticancer nanomedicines have been proven effective in mitigating the side effects of
chemotherapeutic drugs. However, challenges remain in augmenting their therapeutic …

Biomolecule-based nanostructures are inherently multifunctional and harbour diverse
biological activities, which can be explored for cancer nanomedicine. The supramolecular …

The modern eco-friendly materials used in research and innovation today consist of
nanocomposites and bio-nanocomposite polymers. Their unique composite properties make …

Besides the broad development of nanotechnological approaches for cancer diagnosis and
therapy, currently, there is no significant progress in the treatment of different types of brain …

Advanced treatments based on immune system manipulation, gene transcription and
regulation, specific organ and cell targeting, and/or photon energy conversion have …

Brain cancer, especially the most common type of glioblastoma, is highly invasive and
known as one of the most devastating and deadly neoplasms. Despite surgical and medical …

Serum albumin, a natural ligand carrier that is highly concentrated and long-circulating in
the blood, has shown remarkable promise as a carrier for anti-cancer agents. Albumin is …

Drug delivery systems (DDS) are used to achieve a higher therapeutic effects of a
pharmaceutical drug or natural compound in a specific diseased site with minimal …

The impermeable barrier of solid tumors due to the complexity of their components limits the
treatment effect of nanomedicine and hinders its clinical translation. Several methods are …

Glioblastoma (GBM) is an aggressive primary brain cancer, with a 5 year survival of∼ 5%.
Challenges that hamper GBM therapeutic efficacy include (i) tumor heterogeneity,(ii) …